American family physician
American family physician
Audio Summaries
Every issue of American family physician moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
American family physician covers research in these specialties.
Recent summaries
The latest articles summarized from American family physician.
Type 2 Diabetes: Outpatient Insulin Management
Jun 16, 2026
The authors explore effective outpatient insulin management strategies for patients with type 2 diabetes, particularly in cases requiring insulin therapy due to severe hyperglycemia. They emphasize the importance of individualized treatment plans that consider patient-specific factors, such as age and comorbidities, while highlighting the challenges of weight gain, hypoglycemia, and regimen complexity in diabetes management. The paper advocates for the use of basal insulin as a starting point, with careful titration and the potential incorporation of continuous glucose monitoring to enhance diabetes control.
Recurrent UTI in Women: Diagnosis and Management
Jun 16, 2026
The authors investigate the diagnosis and management of recurrent urinary tract infections (UTIs) in women, defined as two or more infections within six months or three or more within a year. They outline risk factors, diagnostic procedures, and treatment guidelines, emphasizing the importance of appropriate antibiotic selection and the role of behavioral modifications and nonantibiotic preventive measures. The article highlights that longer antibiotic therapy does not reduce recurrence risk and that asymptomatic bacteriuria should generally not be treated.
Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management
Jun 16, 2026
The authors aim to address the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD), a prevalent cause of chronic liver disease linked to cardiometabolic risk factors. They emphasize the importance of risk stratification and noninvasive screening for advanced fibrosis, as well as the role of lifestyle interventions and FDA-approved medications in improving patient outcomes. The article highlights the need for primary care monitoring to mitigate long-term complications associated with MASLD.
Gambling Disorder: Diagnosis and Treatment
Jun 16, 2026
The authors aim to address the diagnosis and treatment of gambling disorder, a behavioral addiction that is increasingly prevalent due to greater accessibility to gambling. They highlight the underdiagnosis of the condition, risk factors, and the lack of formal screening guidelines in the U.S., while discussing potential pharmacologic and psychotherapeutic interventions. The paper emphasizes the need for further research on treatment efficacy and the importance of support systems for affected individuals and their families.
Nausea and Vomiting During Pregnancy
Jun 16, 2026
The authors investigate the management of nausea and vomiting during pregnancy, emphasizing the importance of assessing symptom severity using tools like the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score. They outline a treatment hierarchy that begins with behavioral modifications and progresses to pharmacologic interventions, including vitamin B6 and doxylamine for mild to moderate cases, and more aggressive treatments for severe symptoms, including corticosteroids and nutritional support if necessary.
Severe Hypertension: Evaluation and Treatment
May 27, 2026
The authors aim to address the management and evaluation of severe hypertension, particularly in outpatient and inpatient settings, highlighting the prevalence and causes of severe blood pressure elevations among adults. They note that medication nonadherence is a significant factor in outpatient cases, while transient elevations in hospitalized patients are often due to secondary factors. The paper emphasizes the need for careful assessment and management strategies, as aggressive treatment in hospitals may lead to adverse outcomes without improving short-term results.
Postoperative Management After Metabolic Surgery: Role of the Family Physician
May 27, 2026
The authors explore the critical role of family physicians in the postoperative management of patients who have undergone metabolic and bariatric surgery for obesity. They emphasize the need for family physicians to be well-versed in the potential complications, neurohormonal changes, and necessary adjustments in treatment to effectively monitor and support improvements in obesity-related conditions. The paper highlights the importance of comprehensive care in the long-term management of these patients.
HIV Infection: What Is New in Prevention and Treatment?
May 27, 2026
The authors explore recent advancements in the prevention and treatment of HIV, highlighting the importance of screening and a status neutral approach that includes preexposure prophylaxis for HIV-negative individuals and immediate antiretroviral therapy for those diagnosed with HIV. They emphasize the need for tailored management strategies in primary care, including cardiovascular risk assessment and appropriate vaccinations, to improve health outcomes for patients living with HIV.
Skin and Soft Tissue Infections
May 27, 2026
The authors aim to clarify the spectrum of skin and soft tissue infections, their causative agents, and appropriate treatment strategies. They discuss the distinctions between mild and severe infections, emphasizing the role of methicillin-resistant Staphylococcus aureus (MRSA) and the importance of accurate diagnosis and management, including the use of antibiotics and procedures like incision and drainage for abscesses. Additionally, they highlight the common recurrence of cellulitis and associated risk factors, underscoring the need for careful evaluation and treatment planning.
Thrombocytosis: Rapid Evidence Review
May 8, 2026
This review addresses the causes, diagnosis, and management of thrombocytosis, particularly focusing on distinguishing between secondary causes and primary conditions like essential thrombocythemia. The authors emphasize the importance of confirming persistent thrombocytosis through repeated blood tests and genetic testing, as well as the need for risk stratification to guide treatment decisions. They conclude that while hydroxyurea is the primary treatment for essential thrombocythemia, current therapies do not improve survival or prevent disease progression.